Canterbury Health Laboratories has long been at the forefront of biomedical research, both nationally and internationally.
Our dedicated scientists and clinicians have published extensively, examples of which can be found below.
24 resources by "Chris Hemmings".
- Intraabdominal Pacinian corpuscle mimicking a peritoneal tumour deposit
Published May 2021, by Chris Hemmings
- Pathologic assessment of tumour regression following neoadjuvant therapy in pancreatic carcinoma
Published October 2020, by Chris Hemmings
- The prognostic and predictive value of SOX2+ cell densities in patients treated for colorectal cancer
Published April 2020, by Chris Hemmings
- Expression of PDL-1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion
Published August 2018, by Chris Hemmings
- The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3
Published November 2017, by Chris Hemmings
- Immunohistochemical detection of PDL-1 for research studies: Which antibody and what protocol?
Published April 2017, by Chris Hemmings
- Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
Published March 2017, by Chris Hemmings
- Universal molecular screening does not effectively detect Lynch syndrome in clinical practice
Published February 2017, by Chris Hemmings
- Objective analysis of cancer stem cell marker expression using immunohistochemistry
Published January 2017, by Chris Hemmings
- The Generic Surgical Sciences Examination training programme improves participants’ knowledge and pass rates
Published October 2016, by Chris Hemmings
- Low stromal Foxp3+ regulatory T cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
Published December 2015, by Chris Hemmings
- Neoadjuvant chemoradiotherapy for rectal cancer: How important is tumour regression?
Published December 2015, by Chris Hemmings
- Personalising pancreas cancer treatment: When tissue is the issue
Published June 2014, by Chris Hemmings
- National Working Group meeting on ALK diagnostics in lung cancer
Published April 2014, by Chris Hemmings
- A cautionary note regarding detection of PDL-1 expression by tumour-associated macrophages
Published March 2014, by Chris Hemmings
- The changing face of GIST: Implications for pathologists
Published February 2014, by Chris Hemmings
- Morphology, molecular genetics and multidisciplinary management: The face of soft tissue pathology in 2014 and beyond
Published February 2014, by Chris Hemmings
- Metastatic Gastrointestinal Stromal Tumour of the ileum with dual primary c-KIT missense mutations
Published October 2013, by Chris Hemmings
- Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
Published June 2013, by Chris Hemmings
- Obtaining expert opinions in diagnostically difficult cases
Published January 2013, by Chris Hemmings
